Delta Accumulation, LLC Gilead Sciences, Inc. Call Options Transaction History

Delta Accumulation, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $972,928 - $1.11 Million	12,800 Added 88.28%	27,300 $2.1 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $680,328 - $775,104	-8,800 Reduced 37.77%	14,500 $1.2 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $1.45 Million - $2.08 Million	23,300 New	23,300 $2 Million

1,893

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Delta Accumulation, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Accumulation, LLC with notifications on news.